Participating Faculty: Improving Clinical and Economic Outcomes in Multiple Sclerosis

February 25, 2013
Supplements and Featured Publications, Improving Clinical and Economic Outcomes in Multiple Sclerosis [CME/CPE], Volume 19, Issue 2 Suppl

This supplement to The American Journal of Managed Care reviews the immunopathology of multiple sclerosis (MS), the symptoms and natural course of the disease, and the recently revised MS diagnostic criteria. It also describes current and emerging therapeutic strategies for slowing disease progression in patients with MS and their role in the treatment paradigm. Managed care implications, including the costs of MS and factors which influence access to medication, are also discussed.Faculty

A. Scott Mathis, PharmD

Administrative Director

Pharmacy and Medication Use

Pharmacy Department

Monmouth Medical Center

Long Branch, New Jersey

Mark J. Tullman, MD

Director of Clinical Research

MS Center for Innovations in Care

Missouri Baptist Medical Center

St. Louis, Missouri

Faculty Disclosures

These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.

A. Scott Mathis, PharmD, has no relevant financial relationships with commercial interests to disclose.

Mark J. Tullman, MD, has disclosed the following relevant commercial financial relationships:

Consultant/advisory board: Acorda Therapeutics, Allergan, Biogen Idec, Genzyme, Novartis, and Teva Pharmaceuticals

Grants: Acorda Therapeutics

Honoraria: Acorda Therapeutics, Biogen Idec, EMD Serono, Novartis, Pfizer, and Teva Pharmaceuticals

The American Journal of Managed Care

Publishing Staff—Jeff D. Prescott, PharmD, RPh; Kara Guarini, MS; and Ida Delmendo have no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Office of Continuing Professional Education and Physicians’ Education Resource, LLC

Planning Staff—Judy V. Lum, MPA; Elena Beyzarov, PharmD; and Donna Fausak have no relevant financial relationships with commercial interests to disclose.

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.

University of Cincinnati

Planning Staff—Susan P. Tyler, MEd, CMP, CCMEP, has no relevant financial relationships with commercial interests to disclose.

Physician Reviewer—Rick Ricer, MD, has no relevant financial relationships with commercial interests to disclose.

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.

Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, the editorial staff, or any member of the editorial advisory board. Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality, or safety. Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.